The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Observe the safety and tolerability of the single and multiple doses of 601 in DME patients;
study the pharmacokinetic characteristics of single and multiple doses of 601, Observe the
Preliminary efficacy of 601 multiple injections with different doses in the treatment of
patients with DME.